Literature DB >> 19465012

A single dose of passive immunotherapy has extended benefits on synapses and neurites in an Alzheimer's disease mouse model.

Anete Rozkalne1, Tara L Spires-Jones, Edward A Stern, Bradley T Hyman.   

Abstract

Alzheimer's disease (AD) is a neurodegenerative disorder that impairs memory and cognition. One of the major neuropathological hallmarks is the accumulation of the extracellular senile plaques that are mainly composed of amyloid beta (Abeta) protein. Plaques are associated with synapse loss, dystrophic neurites and altered neurite trajectories. A reversal of such morphological changes has been observed days after single dose anti-Abeta immunotherapy. In this study we investigated the extended effects of a single dose of passive anti-Abeta immunotherapy on morphological changes associated with senile plaques. We found that although plaque burden was not reduced 30 days after immunotherapy, there were fewer dystrophic neurites around each plaque, a recovery of synapse density, and normalization of neurite curvature near plaques. Taken together these results suggest that a single dose of immunotherapy is sufficient to cause lasting benefits to the morphology of cortical neurons, implying substantial plasticity of neural circuits despite the continued presence of plaques.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19465012      PMCID: PMC2709805          DOI: 10.1016/j.brainres.2009.05.045

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  36 in total

1.  Imaging of amyloid-beta deposits in brains of living mice permits direct observation of clearance of plaques with immunotherapy.

Authors:  B J Bacskai; S T Kajdasz; R H Christie; C Carter; D Games; P Seubert; D Schenk; B T Hyman
Journal:  Nat Med       Date:  2001-03       Impact factor: 53.440

2.  Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease.

Authors:  F Bard; C Cannon; R Barbour; R L Burke; D Games; H Grajeda; T Guido; K Hu; J Huang; K Johnson-Wood; K Khan; D Kholodenko; M Lee; I Lieberburg; R Motter; M Nguyen; F Soriano; N Vasquez; K Weiss; B Welch; P Seubert; D Schenk; T Yednock
Journal:  Nat Med       Date:  2000-08       Impact factor: 53.440

3.  Plaque-induced abnormalities in neurite geometry in transgenic models of Alzheimer disease: implications for neural system disruption.

Authors:  R Le; L Cruz; B Urbanc; R B Knowles; K Hsiao-Ashe; K Duff; M C Irizarry; H E Stanley; B T Hyman
Journal:  J Neuropathol Exp Neurol       Date:  2001-08       Impact factor: 3.685

4.  Immunization reverses memory deficits without reducing brain Abeta burden in Alzheimer's disease model.

Authors:  Jean-Cosme Dodart; Kelly R Bales; Kimberley S Gannon; Stephen J Greene; Ronald B DeMattos; Chantal Mathis; Cynthia A DeLong; Su Wu; Xin Wu; David M Holtzman; Steven M Paul
Journal:  Nat Neurosci       Date:  2002-05       Impact factor: 24.884

5.  Imaging Abeta plaques in living transgenic mice with multiphoton microscopy and methoxy-X04, a systemically administered Congo red derivative.

Authors:  William E Klunk; Brian J Bacskai; Chester A Mathis; Stephen T Kajdasz; Megan E McLellan; Matthew P Frosch; Manik L Debnath; Daniel P Holt; Yanming Wang; Bradley T Hyman
Journal:  J Neuropathol Exp Neurol       Date:  2002-09       Impact factor: 3.685

6.  In vivo multiphoton imaging of a transgenic mouse model of Alzheimer disease reveals marked thioflavine-S-associated alterations in neurite trajectories.

Authors:  J D D'Amore; S T Kajdasz; M E McLellan; B J Bacskai; E A Stern; B T Hyman
Journal:  J Neuropathol Exp Neurol       Date:  2003-02       Impact factor: 3.685

Review 7.  The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.

Authors:  John Hardy; Dennis J Selkoe
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728

Review 8.  Imaging amyloid-beta deposits in vivo.

Authors:  Brian J Bacskai; William E Klunk; Chester A Mathis; Bradley T Hyman
Journal:  J Cereb Blood Flow Metab       Date:  2002-09       Impact factor: 6.200

9.  Intracerebroventricular amyloid-beta antibodies reduce cerebral amyloid angiopathy and associated micro-hemorrhages in aged Tg2576 mice.

Authors:  Deepak R Thakker; Marcy R Weatherspoon; Jonathan Harrison; Thomas E Keene; Deanna S Lane; William F Kaemmerer; Gregory R Stewart; Lisa L Shafer
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-25       Impact factor: 11.205

10.  Reversible memory loss in a mouse transgenic model of Alzheimer's disease.

Authors:  Linda A Kotilinek; Brian Bacskai; Marcus Westerman; Takeshi Kawarabayashi; Linda Younkin; Bradley T Hyman; Steven Younkin; Karen H Ashe
Journal:  J Neurosci       Date:  2002-08-01       Impact factor: 6.167

View more
  12 in total

Review 1.  Dendritic vulnerability in neurodegenerative disease: insights from analyses of cortical pyramidal neurons in transgenic mouse models.

Authors:  Jennifer I Luebke; Christina M Weaver; Anne B Rocher; Alfredo Rodriguez; Johanna L Crimins; Dara L Dickstein; Susan L Wearne; Patrick R Hof
Journal:  Brain Struct Funct       Date:  2010-02-24       Impact factor: 3.270

Review 2.  The intersection of amyloid beta and tau at synapses in Alzheimer's disease.

Authors:  Tara L Spires-Jones; Bradley T Hyman
Journal:  Neuron       Date:  2014-05-21       Impact factor: 17.173

3.  AD synapses contain abundant Aβ monomer and multiple soluble oligomers, including a 56-kDa assembly.

Authors:  Sophie Sokolow; Kristen M Henkins; Tina Bilousova; Carol A Miller; Harry V Vinters; Wayne Poon; Gregory M Cole; Karen Hoppens Gylys
Journal:  Neurobiol Aging       Date:  2011-07-07       Impact factor: 4.673

Review 4.  Probing the biology of Alzheimer's disease in mice.

Authors:  Karen H Ashe; Kathleen R Zahs
Journal:  Neuron       Date:  2010-06-10       Impact factor: 17.173

5.  Plaque-Associated Local Toxicity Increases over the Clinical Course of Alzheimer Disease.

Authors:  Alberto Serrano-Pozo; Rebecca A Betensky; Matthew P Frosch; Bradley T Hyman
Journal:  Am J Pathol       Date:  2015-12-11       Impact factor: 4.307

6.  Calcineurin inhibition with FK506 ameliorates dendritic spine density deficits in plaque-bearing Alzheimer model mice.

Authors:  Anete Rozkalne; Bradley T Hyman; Tara L Spires-Jones
Journal:  Neurobiol Dis       Date:  2010-12-04       Impact factor: 5.996

7.  Quaternary Structure Defines a Large Class of Amyloid-β Oligomers Neutralized by Sequestration.

Authors:  Peng Liu; Miranda N Reed; Linda A Kotilinek; Marianne K O Grant; Colleen L Forster; Wei Qiang; Samantha L Shapiro; John H Reichl; Angie C A Chiang; Joanna L Jankowsky; Carrie M Wilmot; James P Cleary; Kathleen R Zahs; Karen H Ashe
Journal:  Cell Rep       Date:  2015-06-04       Impact factor: 9.423

8.  Genetic modulation of soluble Aβ rescues cognitive and synaptic impairment in a mouse model of Alzheimer's disease.

Authors:  Stephanie W Fowler; Angie C A Chiang; Ricky R Savjani; Megan E Larson; Mathew A Sherman; Dorothy R Schuler; John R Cirrito; Sylvain E Lesné; Joanna L Jankowsky
Journal:  J Neurosci       Date:  2014-06-04       Impact factor: 6.167

9.  Alzheimer's disease: synapses gone cold.

Authors:  Robert M Koffie; Bradley T Hyman; Tara L Spires-Jones
Journal:  Mol Neurodegener       Date:  2011-08-26       Impact factor: 14.195

Review 10.  Spines, plasticity, and cognition in Alzheimer's model mice.

Authors:  Tara Spires-Jones; Shira Knafo
Journal:  Neural Plast       Date:  2011-11-28       Impact factor: 3.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.